36 results
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
9:06am
Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical … Control of the U.S. Department of the Treasury
(“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union, His
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
9:06am
, on the SEC’s website at http://www.sec.gov or by contacting Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New … Securities, LLC Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, New York 10017 or by telephone at (212) 518-9544
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
19 Jan 24
Entry into a Material Definitive Agreement
4:19pm
subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department … Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union, His
8-K
yy9 taq7sls8qje
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
424B3
v9q5h5a9e
21 Apr 23
Prospectus supplement
4:18pm
POS AM
o5ybjffexqpu
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
gvza1pz5thuf5ph9u
9 Sep 22
Prospectus supplement
5:05pm
8-K
EX-10.2
ubz8k1xr6
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
8-K
oacemc
12 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:26am